View in EDS HTML Full Text PDF Full Text

CD8+ T-NK cell crosstalk establishes preemptive immunosurveillance to eliminate antigen-escape tumors.

Saved in:
Bibliographic Details
Title: CD8+ T-NK cell crosstalk establishes preemptive immunosurveillance to eliminate antigen-escape tumors.
Authors: Uzhachenko RV; Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Meharry Medical College School of Medicine, Nashville, TN, United States., González Ochoa S; Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Meharry Medical College School of Medicine, Nashville, TN, United States., Kanagasabai T; Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Meharry Medical College School of Medicine, Nashville, TN, United States., Rajakaruna H; The Office for Research and Innovation, Meharry Medical College, Nashville, TN, United States., Thounaojam MC; Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Meharry Medical College School of Medicine, Nashville, TN, United States.; Department of Biomedical Sciences, Meharry Medical College School of Graduate Studies, Nashville, TN, United States., de Aquino MTP; Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Meharry Medical College School of Medicine, Nashville, TN, United States., Rana T; Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Meharry Medical College School of Medicine, Nashville, TN, United States., Costa L; Center for Laser Applications, University of Tennessee Space Institute, Tullahoma, TN, United States., Terekhov A; Center for Laser Applications, University of Tennessee Space Institute, Tullahoma, TN, United States., Hofmeister WH; Center for Laser Applications, University of Tennessee Space Institute, Tullahoma, TN, United States., Sayers TJ; Basic Research Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, United States.; Cancer and Inflammation Program, National Cancer Institute-Frederick, Frederick, MD, United States., Boyer C; Centre d'Immunologie de Marseille-Luminy, Aix Marseille Université UM2, Institut National de la Santé et de la Recherche Médicale U1104, Centre National de la Recherche Scientifique UMR7280, Marseille, France., Ivanova AV; Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Meharry Medical College School of Medicine, Nashville, TN, United States., Goodwin JS; Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Meharry Medical College School of Medicine, Nashville, TN, United States., Schmitt-Verhulst AM; Centre d'Immunologie de Marseille-Luminy, Aix Marseille Université UM2, Institut National de la Santé et de la Recherche Médicale U1104, Centre National de la Recherche Scientifique UMR7280, Marseille, France., Shanker A; Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Meharry Medical College School of Medicine, Nashville, TN, United States.; The Office for Research and Innovation, Meharry Medical College, Nashville, TN, United States.; Basic Research Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, United States.; Cancer and Inflammation Program, National Cancer Institute-Frederick, Frederick, MD, United States.; Centre d'Immunologie de Marseille-Luminy, Aix Marseille Université UM2, Institut National de la Santé et de la Recherche Médicale U1104, Centre National de la Recherche Scientifique UMR7280, Marseille, France.
Source: Frontiers in immunology [Front Immunol] 2025 Sep 22; Vol. 16, pp. 1593913. Date of Electronic Publication: 2025 Sep 22 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41058706
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: CD8<superscript>+</superscript> T-NK cell crosstalk establishes preemptive immunosurveillance to eliminate antigen-escape tumors.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Uzhachenko+RV%22">Uzhachenko RV</searchLink>; Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Meharry Medical College School of Medicine, Nashville, TN, United States.<br /><searchLink fieldCode="AU" term="%22González+Ochoa+S%22">González Ochoa S</searchLink>; Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Meharry Medical College School of Medicine, Nashville, TN, United States.<br /><searchLink fieldCode="AU" term="%22Kanagasabai+T%22">Kanagasabai T</searchLink>; Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Meharry Medical College School of Medicine, Nashville, TN, United States.<br /><searchLink fieldCode="AU" term="%22Rajakaruna+H%22">Rajakaruna H</searchLink>; The Office for Research and Innovation, Meharry Medical College, Nashville, TN, United States.<br /><searchLink fieldCode="AU" term="%22Thounaojam+MC%22">Thounaojam MC</searchLink>; Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Meharry Medical College School of Medicine, Nashville, TN, United States.; Department of Biomedical Sciences, Meharry Medical College School of Graduate Studies, Nashville, TN, United States.<br /><searchLink fieldCode="AU" term="%22de+Aquino+MTP%22">de Aquino MTP</searchLink>; Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Meharry Medical College School of Medicine, Nashville, TN, United States.<br /><searchLink fieldCode="AU" term="%22Rana+T%22">Rana T</searchLink>; Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Meharry Medical College School of Medicine, Nashville, TN, United States.<br /><searchLink fieldCode="AU" term="%22Costa+L%22">Costa L</searchLink>; Center for Laser Applications, University of Tennessee Space Institute, Tullahoma, TN, United States.<br /><searchLink fieldCode="AU" term="%22Terekhov+A%22">Terekhov A</searchLink>; Center for Laser Applications, University of Tennessee Space Institute, Tullahoma, TN, United States.<br /><searchLink fieldCode="AU" term="%22Hofmeister+WH%22">Hofmeister WH</searchLink>; Center for Laser Applications, University of Tennessee Space Institute, Tullahoma, TN, United States.<br /><searchLink fieldCode="AU" term="%22Sayers+TJ%22">Sayers TJ</searchLink>; Basic Research Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, United States.; Cancer and Inflammation Program, National Cancer Institute-Frederick, Frederick, MD, United States.<br /><searchLink fieldCode="AU" term="%22Boyer+C%22">Boyer C</searchLink>; Centre d'Immunologie de Marseille-Luminy, Aix Marseille Université UM2, Institut National de la Santé et de la Recherche Médicale U1104, Centre National de la Recherche Scientifique UMR7280, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Ivanova+AV%22">Ivanova AV</searchLink>; Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Meharry Medical College School of Medicine, Nashville, TN, United States.<br /><searchLink fieldCode="AU" term="%22Goodwin+JS%22">Goodwin JS</searchLink>; Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Meharry Medical College School of Medicine, Nashville, TN, United States.<br /><searchLink fieldCode="AU" term="%22Schmitt-Verhulst+AM%22">Schmitt-Verhulst AM</searchLink>; Centre d'Immunologie de Marseille-Luminy, Aix Marseille Université UM2, Institut National de la Santé et de la Recherche Médicale U1104, Centre National de la Recherche Scientifique UMR7280, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Shanker+A%22">Shanker A</searchLink>; Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Meharry Medical College School of Medicine, Nashville, TN, United States.; The Office for Research and Innovation, Meharry Medical College, Nashville, TN, United States.; Basic Research Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, United States.; Cancer and Inflammation Program, National Cancer Institute-Frederick, Frederick, MD, United States.; Centre d'Immunologie de Marseille-Luminy, Aix Marseille Université UM2, Institut National de la Santé et de la Recherche Médicale U1104, Centre National de la Recherche Scientifique UMR7280, Marseille, France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2025 Sep 22; Vol. 16, pp. 1593913. <i>Date of Electronic Publication: </i>2025 Sep 22 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41058706
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2025.1593913
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1593913
    Titles:
      – TitleFull: CD8+ T-NK cell crosstalk establishes preemptive immunosurveillance to eliminate antigen-escape tumors.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Uzhachenko RV
      – PersonEntity:
          Name:
            NameFull: González Ochoa S
      – PersonEntity:
          Name:
            NameFull: Kanagasabai T
      – PersonEntity:
          Name:
            NameFull: Rajakaruna H
      – PersonEntity:
          Name:
            NameFull: Thounaojam MC
      – PersonEntity:
          Name:
            NameFull: de Aquino MTP
      – PersonEntity:
          Name:
            NameFull: Rana T
      – PersonEntity:
          Name:
            NameFull: Costa L
      – PersonEntity:
          Name:
            NameFull: Terekhov A
      – PersonEntity:
          Name:
            NameFull: Hofmeister WH
      – PersonEntity:
          Name:
            NameFull: Sayers TJ
      – PersonEntity:
          Name:
            NameFull: Boyer C
      – PersonEntity:
          Name:
            NameFull: Ivanova AV
      – PersonEntity:
          Name:
            NameFull: Goodwin JS
      – PersonEntity:
          Name:
            NameFull: Schmitt-Verhulst AM
      – PersonEntity:
          Name:
            NameFull: Shanker A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 22
              M: 09
              Text: 2025 Sep 22
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1